Carina Biotech is an Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers
Carina Biotech is an Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. The company focuses on next-generation CAR-T technologies that utilize the patient's immune system to combat cancer, aiming for patient-specific treatments with minimal off-cancer damage.